Skip to main content

Intellia Therapeutics, Inc.

HQUS

No corporate parent is shown

0
ownership levels above this company
4
supply relationships · 1 with suppliers, 3 with customers
0
linked facilities
0
export-control designations found
0
sovereign commitments to funds investing in this company
Scrutica id
org-intellia-therapeutics-inc
Name and corporate-form variants · 2 Intellia Therapeutics · INTELLIA THERAPEUTICS INC

Ownership chain

The main chain follows the strongest parent claim by confidence, source authority and date. Other named parents appear alongside it.

  1. Intellia Therapeutics, Inc. (US)

    Starting organisation.

End of the displayed chain

The displayed ownership chain ends at Intellia Therapeutics, Inc.

Suppliers and customers

Annual dollar amounts refer to the fiscal year shown; sources include SEC filings, company disclosures and licensed supply-chain data. Figures open their source details. Disclosures more than 5 years old are marked historical. Records are grouped by counterparty, with historical records after newer or undated records within each group. A product or service, a percentage (the supplier’s share of one product line in the customer’s inputs) and a sole-source mark appear only where the record’s cited source states them for the pair; alternative suppliers may exist outside this corpus.

Upstream Suppliers · 1 record
Downstream Customers · 3 records
  • SEC segment disclosure: INTELLIA THERAPEUTICS INC → REGENERON PHARMACEUTICALS

    FY2024
  • SEC segment disclosure: INTELLIA THERAPEUTICS INC → KYVERNA THERAPEUTICS INC

    FY2022
  • SEC segment disclosure: INTELLIA THERAPEUTICS INC → NOVARTIS AG

    FY2021

Explore full supply chain graph →

Related analysis

Source coverage

Geographic revenue, business segments and capital allocation are unavailable from the licensed financial dataset. No stock ticker or SEC filing identifier is recorded for Intellia Therapeutics, Inc. The public industry classification (SIC, NAICS) is also unrecorded. Sources and publication limits.